[ 1 ] 黄紫蓉. 现代口服避孕药的发展与研制特点[J]. 实用妇产科杂 志，2009，25（2）：67. link1

[ 2 ] 朱 焰，谢淑武，曹 霖. 新型孕激素及抗孕激素国外研发进 展[J]. 中国新药杂志，2011，20（19）：23. link1

[ 3 ] Deb S，Campbell B K，Pincott-Allen C，et al. Quantifying effect of combined oral contraceptive pill on functional ovarian reserve as measured by serum anti-Müllerian hormone and small antral follicle count using three- dimensional ultrasound[J]. Ultrasound in Obstetrics & Gynecology，2012，39（5）：574-580. link1

[ 4 ] Holt V L，Cushing- Haugen K L，Daling J R. Oral contraceptives，tubal sterilization，and functional ovarian cyst risk[J]. Obstetrics and Gynecology，2003，102（2）：252-258. link1

[ 5 ] Spona J，Elstein M，Feichtinger W，et al. Shorter pill-free interval in combined oral contraceptives decreases follicular development[J]. Contraception，1996，54（2）：71-77. link1

[ 6 ] Anzai Y，Heger-Manhn D，Schellschmidt I，et al.Suppression of ovarian activity with a low-dose 21/7-day regimen oral contraceptive containing ethinylestradiol 20 mcg/drospirenone 3 mg in Japanese and Caucasian women[J]. Contraception，2012，86（1）： 28-34. link1

[ 7 ] Schlaff W D，Lynch A M ，Hughes H D，et al. Manipulation of the pill- free interval in oral contraceptive pill users：The effect on follicular suppression[J]. American Journal of Obstetrics and Gynecology，2004，190（4）：943-951. link1

[ 8 ] van Heusden A M，Fauser B C. Activity of the pituitary-ovarian axis in the pill- free interval during use of low- dose combined oral contraceptives[J]. Contraception，1999，59（4）：237-243. link1

[ 9 ] Vandever M A，Kuehl T J，Sulak P J，et al. Evaluation of pituitary-ovarian axis suppression with three oral contraceptive regimens[J]. Contraception，2008，77（3）：162-170. link1

[10] Schallmayer S，Hughes B M. Impact of oral contraceptiron and neuroticism on cardiovascular stress reactivity across the menstrual cycle[J].Psychology Health & Medicine，2010，15（1）： 105-115. link1

[11] Gallo M F，Nanda K，Grimes D A，et al. Twenty micrograms vs >20 microg estrogen oral contraceptives for contraception： Systematic review of randomized controlled trials[J]. Contraception，2005，71（3）：162-169. link1

[12] Baerwald A R，Pierson R A. Ovarian follicular development during the use of oral contraception：A review[J] .Journal of Obstetrics and Gynaecology Canada，2004，26（1）：19-24. link1

[13] Brenner P F，Mishell D R Jr，Stanczyk F Z，et al. Serum levels of d- norgestrel，luteinizing hormone，follicle- stimulating hormone，estradiol and progesterone in women during and following ingestion of combination oral contraceptives containing DLnorgestrel[J]. American Journal of Obstetrics and Gynecology， 1977，129（2）：133-140. link1

[14] Killick S R，Fitzgerald C，Davis A. Ovarian activity in women taking an oral contraceptive containing 20 microg ethinyl estradiol and 150 microg desogestrel：Effects of low estrogen doses during the hormone free interval[J]. American Journal of Obstetrics and Gynecology，1998，179（1）：S18-S24. link1

[15] Bentzen J G，Forman J L，Pinborg A，et al. Ovarian reserve parameters：A comparison between users and non- users of hormonal contraception[J]. Reproductive Biomedicine Online， 2012，25（6）：612-619. link1

[16] Rabe T，Nitsche D C，Runnebaum B. The effects of monophasic and triphasic oral contraceptives on ovarian function and endometrial thickness[J].The European Journal of Contraception & Reproductive Health Care，1997，2（1）：39-51. link1

[17] World Health Organization. A randomized double-blind study of six combined oral contraceptive pills[J]. Contraception，1982， 25（3）：231-241. link1

[18] Elomaa K，Rolland R，Brosens I，et al. Omitting the first oral contraceptive pills of the cycle does not automatically lead to ovulation[J]. American Journal of Obstetrics and Gynecology， 1998，179（1）：41-46. link1

[19] Klipping C，Duijkers I，Trummer D，et al. Suppression of ovarian activity with a drospirenone-containing oral contraceptive in a 24/4 regimen[J]. Contraception，2008，78（1）：16-25. link1

[20] Zapata L B，Steenland M W，Brahmi D，et al. Effect of missed combined hormonal contraceptives on contraceptive effectiveness：A systematic review[J]. Contraception，2013，87（5）： 685-700. link1

[21] Elomaa K，Lähteenmäki P. Ovulatory potential of preovulatory sized follicles during oral contraceptive treatment[J]. Contraception，1999，60（5）：275-279. link1

[22] Sulak P J，Scow R D，Preece C，et al. Hormone withdrawal symptoms in oral contraceptive users[J]. Obstetrics and Gynecology，2000，95（2）：261-266. link1

[23] Anderson F D，Gibbons W，Portman D. Safety and efficacy of an extended- regimen oral contraceptive utilizing continuous low-dose ethinyl estradiol[J].Contraception ，2006，73（3）：229- 234. link1

[24] Yonkers K，Brown C，Pearlstein T，et al. Efficacy of a new low- dose oral contraceptive with drospirenone in premenstrual dysphoric disorder[J]. American Journal of Obstetrics and Gynecology，2005，106（3）：492-501. link1

[25] Coffee A L，Sulak P J，Kuehl T J. Long- term assessment of symptomatology and satisfaction of an extended oral contraceptive regimen[J].Contraception，2007，75（6）：444-449. link1

[26] Sullivan H，Furniss H，Spona J，et al. Effect of 21-day and 24- day oral contraceptive regimens containing gestodene（60 μg） and ethinyl estradiol（15 μg）on ovarian activity[J].Fertility and Sterility，1999，72（1）：115-120. link1

[27] Willis S A，Kuehl T J，Spiekerman A M，et al. Greater inhibition of the pituitary-ovarian axis in oral contraceptive regimens with a shortened hormone-free interval[J]. Contraception，2006， 74（2）：100-103. link1

[28] Fels H，Steward R，Melamed A，et al. Comparison of serum and cervical mucus hormone levels during hormone- free interval of 24/4 vs. 21/7 combined oral contraceptives[J]. Contraception，2013，87（6）：732-737. link1

[29] Rible R D，Taylor D，Wilson M L，et al. Follicular development in a 7-day versus 4-day hormone-free interval with an oral contraceptive containing 20 mcg ethinyl estradiol and 1 mg norethindrone acetate[J]. Contraception，2009，79（3）：182-188. link1

[30] 陈丽刚，熊承良. 口服避孕药中孕激素的应用及进展[J]. 国外医学（计划生育/生殖健康分册），2006，25（1）：44-47. link1

[31] Africander D，Verhoog N，Hapgood J P. Molecular mechanisms of steroid receptor mediated actions by synthetic progestins used in HRT and contraception[J]. Steroids，2011，76（7）： 636-652. link1

[32] Barad D H，Kim A，Kubba H，et al. Does hormonal contraception prior to in vitro fertilization（IVF）negatively affect oocyte yields? - a pilot study[J]. Reproductive Biology and Endocrinology，2013，11：28-33. link1

[33] Dinger J，Minh T D，Buttmann N，et al. Effectiveness of oral contraceptive pills in a large US cohort comparing progestogen and regimen[J]. Obstetrics and Gynecology，2011，117（1）：33- 40. link1

[34] Cho M，Atrio J，Lim A H，et al. Pituitary and ovarian hormone activity during the 7-day hormone-free interval of various combined oral contraceptive regimens[J]. Contraception，2014，90 （1）：94-96. link1